TrialScience translational medicine2012

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.

Andrew J Rech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.